Hospira Docetaxel Injection 80 mg/8 mL, single vial

Active ingredient:

docetaxel, Quantity: 10 mg/mL

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Docetaxel

Pharmaceutical form:

Injection

Composition:

Excipient Ingredients: citric acid; ethanol absolute; polysorbate 80; polyethylene glycol monomethyl ether

Administration route:

Intravenous Infusion

Units in package:

1 X 10 mL vial

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Breast cancer, Non-small cell lung cancer, Stomach cancer, Head and neck cancer, Ovarian cancer, Oesophageal cancer, Uterine cancer, Prostate cancer

Product summary:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2013-10-25